These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22815087)

  • 21. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperforin activates gene transcription involving transient receptor potential C6 channels.
    Thiel G; Rössler OG
    Biochem Pharmacol; 2017 Apr; 129():96-107. PubMed ID: 28110963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms controlling neurite outgrowth in a pheochromocytoma cell line: the role of TRPC channels.
    Kumar S; Chakraborty S; Barbosa C; Brustovetsky T; Brustovetsky N; Obukhov AG
    J Cell Physiol; 2012 Apr; 227(4):1408-19. PubMed ID: 21618530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat.
    Chatterjee S; Filippov V; Lishko P; Maximyuk O; Nöldner M; Krishtal O
    Life Sci; 1999; 65(22):2395-405. PubMed ID: 10597894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. St. John's Wort enhances the synaptic activity of the nucleus of the solitary tract.
    Vance KM; Ribnicky DM; Hermann GE; Rogers RC
    Nutrition; 2014; 30(7-8 Suppl):S37-42. PubMed ID: 24985104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No activation of human pregnane X receptor by hyperforin-related phloroglucinols.
    Kandel BA; Ekins S; Leuner K; Thasler WE; Harteneck C; Zanger UM
    J Pharmacol Exp Ther; 2014 Mar; 348(3):393-400. PubMed ID: 24259679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort.
    Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological and genetic inhibition of TRPC6-induced gene transcription.
    Scheuble J; Rössler OG; Ulrich M; Thiel G
    Eur J Pharmacol; 2020 Nov; 886():173357. PubMed ID: 32758574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diacylglycerol analogues activate second messenger-operated calcium channels exhibiting TRPC-like properties in cortical neurons.
    Tu P; Kunert-Keil C; Lucke S; Brinkmeier H; Bouron A
    J Neurochem; 2009 Jan; 108(1):126-38. PubMed ID: 19094061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
    Dinamarca MC; Cerpa W; Garrido J; Hancke JL; Inestrosa NC
    Mol Psychiatry; 2006 Nov; 11(11):1032-48. PubMed ID: 16880827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
    Singer A; Wonnemann M; Müller WE
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1363-8. PubMed ID: 10454515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.